MoneyWorks4Me

Gujarat Themis Biosyn informs about disclosures

22 Dec 2023 Evaluate
Gujarat Themis Biosyn has informed that it enclosed Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 21, 2023 for Pharmaceuticals Business Group (India).

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..